Mangalam Drugs and Organics Ltd.

BSE: MANGALAM532637ISIN INE584F01014

Healthcare
Pharmaceuticals

Share price

₹29.50+0.16 (+0.55%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹67.25
52W low: ₹22.70
Off 52W high: -56.13%
1M return: -1.11%
3M return: +9.38%
6M return: 0.00%
1Y return: -55.33%
20D avg volume: 3,161
50 DMA: ₹31.11
200 DMA: ₹30.91

Key ratios Consolidated

Market cap: ₹46.69 Cr
Current price: ₹29.50
52W high / low: ₹67.25 / ₹22.70
Face value: ₹10.00
P/E: -1.22
P/B: 0.45
EPS (TTM): ₹-24.16
Book value / share: ₹65.11
ROE: —
ROCE: -27.30%
Operating margin: —
Net margin: —
Debt / equity: 1.02
Net debt: ₹104.78 Cr
Interest cover: -2.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 105.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	57.12	67.29	58.49	49.54	57.35	73.04	88.71	79.94	76.54	—
	0.11	0.09	0.11	0.03	0.00	0.21	0.14	0.14	0.02	—
	57.23	67.38	58.60	49.57	57.35	73.25	88.85	80.08	76.56	—
	63.98	80.65	68.43	62.04	70.35	71.61	87.48	78.88	75.97	—
	33.59	35.51	37.06	28.89	23.33	41.76	44.86	43.40	40.53	—
	0.00	0.00	0.00	0.00	0.00	6.19	3.72	2.35	6.07	—
	8.91	8.49	8.39	7.53	9.38	10.50	10.34	10.18	9.57	—
	3.68	3.08	4.05	5.03	4.04	4.03	3.49	3.67	3.75	—
	4.09	4.66	4.46	4.63	4.48	4.70	4.05	3.98	3.88	—
	14.15	17.26	14.46	11.79	12.87	17.01	18.68	20.40	18.37	—
	-6.75	-13.27	-9.84	-12.47	-13.00	1.64	1.37	1.20	0.58	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	-6.75	-13.27	-9.84	-12.47	-13.00	1.64	1.37	1.20	0.58	—
	0.89	0.15	0.00	5.12	0.80	1.58	0.08	1.49	2.10	—
	-7.64	-13.42	-9.84	-7.35	-13.80	0.06	1.29	2.69	2.69	—
	-4.83	-8.48	-6.21	-4.64	-8.72	0.04	0.81	1.70	1.70	—
Key metrics
	1.02	-5.53	-1.33	-2.81	-4.48	10.37	8.91	8.85	8.21	—
	1.80%	-8.20%	-2.30%	-5.70%	-7.80%	14.20%	10.00%	11.10%	10.70%	—
	-13.40%	-19.90%	-16.80%	-14.80%	-24.10%	0.10%	1.50%	3.40%	3.50%	—
	—	-8.60%	—	-5.00%	—	3.20%	—	—	—	—
	-0.40%	-7.90%	-34.10%	-38.00%	-25.10%	—	—	—	—	—
	44.60%	-22,466.70%	-862.80%	-373.20%	-613.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	232.44	232.13	318.23	—
	0.34	0.76	0.50	—
	232.78	232.90	318.73	—
	275.10	281.47	313.95	—
	135.05	124.79	170.56	—
	0.00	0.00	18.33	—
	33.32	33.79	40.59	—
	15.84	16.21	14.93	—
	17.84	18.22	16.61	—
	57.66	56.37	74.45	—
	-42.33	-48.57	4.79	—
	0.00	0.00	0.00	—
	-42.33	-48.57	4.79	—
	6.16	4.17	1.94	—
	-38.25	-44.40	6.72	—
	-24.16	-28.05	4.25	—
Key metrics
	-8.65	-14.14	36.33	—
	-3.72%	-6.10%	11.40%	—
	-16.46%	-19.10%	2.10%	—
	—	-27.30%	11.30%	—
	-22.27%	-27.10%	—	—
	—	-760.70%	—	—
	—	-7.72	22.39	—
	—	-0.09	6.34	—
	—	1.02	0.54	—
	—	104.78	78.58	—
	—	105.6	99.5	—
Balance sheet
	—	314.97	366.42	—
	—	155.71	198.98	—
	—	0.70	2.59	—
	—	40.30	39.07	—
	—	102.77	138.80	—
	—	8.72	11.94	—
	—	115.68	133.60	—
	—	75.91	91.15	—
	—	196.58	191.60	—
	—	105.48	81.17	—
	—	96.92	71.94	—
	—	8.56	9.23	—
	—	103.06	148.98	—
Cash flow
	—	4.18	42.59	—
	—	-11.72	-19.47	—
	—	5.66	-21.71	—
	—	11.90	20.20	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	57.12	67.29	58.49	49.54	57.35	73.04	88.71	79.94	76.54	—
	0.11	0.09	0.11	0.03	0.00	0.14	0.13	0.14	0.02	—
	57.23	67.38	58.60	49.57	57.35	72.90	88.84	80.08	76.56	—
	63.89	80.29	68.38	61.94	70.28	71.18	87.36	78.88	75.97	—
	33.59	35.51	37.06	28.89	23.33	41.76	44.86	43.40	40.53	—
	0.00	0.00	0.00	0.00	0.00	6.19	3.72	2.35	6.07	—
	8.82	8.18	8.38	7.59	9.31	10.50	10.34	10.18	9.57	—
	3.68	3.08	4.05	5.03	4.04	4.03	3.49	3.67	3.75	—
	3.99	4.56	4.37	4.53	4.38	4.61	3.93	3.97	3.87	—
	14.25	17.30	14.50	11.73	12.96	16.67	18.68	20.41	18.37	—
	-6.66	-12.91	-9.78	-12.37	-12.93	1.73	1.48	1.20	0.58	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-6.66	-12.91	-9.78	-12.37	-12.93	1.73	1.48	1.20	0.58	—
	0.89	0.15	0.00	5.12	0.80	1.58	0.08	1.49	2.10	—
	-7.55	-13.06	-9.78	-7.25	-13.73	0.15	1.40	2.69	2.69	—
	-4.77	-8.25	-6.18	-4.58	-8.67	0.20	0.89	1.70	1.70	—
Key metrics
	1.01	-5.27	-1.36	-2.81	-4.51	10.37	8.90	8.84	8.20	—
	1.80%	-7.80%	-2.30%	-5.70%	-7.90%	14.20%	10.00%	11.10%	10.70%	—
	-13.20%	-19.40%	-16.70%	-14.60%	-23.90%	0.20%	1.60%	3.40%	3.50%	—
	—	-8.30%	—	-5.00%	—	3.30%	—	—	—	—
	-0.40%	-7.90%	-34.10%	-38.00%	-25.10%	—	—	—	—	—
	45.00%	-8,806.70%	-798.60%	-369.50%	-610.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	232.44	232.13	318.23	—
	0.34	0.76	0.15	—
	232.78	232.90	318.38	—
	274.50	280.88	313.39	—
	135.05	124.79	170.56	—
	0.00	0.00	18.33	—
	32.97	33.46	40.59	—
	15.84	16.21	14.93	—
	17.45	17.84	16.38	—
	57.78	56.49	74.13	—
	-41.72	-47.99	4.99	—
	0.00	0.00	0.00	—
	-41.72	-47.99	4.99	—
	6.16	-4.17	1.94	—
	-37.64	-43.81	6.92	—
	-23.78	-27.68	8.74	—
Key metrics
	-8.43	-13.94	36.30	—
	-3.63%	-6.00%	11.40%	—
	-16.19%	-18.90%	2.20%	—
	—	-26.80%	11.40%	—
	-22.27%	-27.10%	—	—
	—	-733.10%	—	—
	—	-7.74	22.72	—
	—	-0.09	6.20	—
	—	0.99	0.55	—
	—	101.39	78.60	—
	—	116.7	99.3	—
Balance sheet
	—	308.14	359.24	—
	—	155.69	198.99	—
	—	0.67	2.57	—
	—	40.30	39.07	—
	—	102.77	138.80	—
	—	8.71	0.00	—
	—	108.85	111.52	—
	—	68.86	91.32	—
	—	189.49	184.74	—
	—	102.06	81.17	—
	—	94.56	71.94	—
	—	7.50	9.23	—
	—	103.32	148.66	—
Cash flow
	—	4.16	42.92	—
	—	-11.72	19.47	—
	—	5.66	-21.71	—
	—	11.90	-20.20	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -22.27%
Profit YoY (TTM): -296.63%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -22.27%
Profit YoY (TTM): -291.91%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 35.65%

Quarter	September 2026	June 2026
Promoter %	35.65%	35.65%

Holder	Type	Holding	Previous	Change
Shree Rasbihari Trading & Investment Pvt Ltd	Promoter Group	6.21%	6.21%	0.00%
Shri Jb Pharma Private Limited	Promoter Group	6.00%	6.00%	0.00%
Govardhan Murlidhar Dhoot	Promoter	4.21%	0.98%	+3.23%
Brijmohan Murlidhar Dhoot	Promoter	3.57%	3.57%	0.00%
Shree Kishoriju Trading & Investment Pvt Ltd	Promoter Group	3.21%	3.21%	0.00%
Shweta Govardhan Dhoot	Promoter	2.59%	—	—
Radhika Ajay Dhoot	Promoter	1.85%	1.85%	0.00%
Smita Aditya Dhoot	Promoter	1.85%	1.85%	0.00%
Ramniwas Ramdayal Dhoot	Promoter	1.74%	—	—
Anish Dwivedi	Public	1.42%	1.01%	+0.41%
Raj Exports Pvt Ltd	Promoter Group	1.21%	1.21%	0.00%
Thakkalapalli Sampath Rao	Public	1.03%	1.03%	0.00%
Rekha Govardhan Dhoot	Promoter	0.93%	—	—
Ajay Ramniwas Dhoot	Promoter	0.88%	0.88%	0.00%
Jyoti Brijmohan Dhoot	Promoter	0.66%	0.66%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Mangalam Drugs and Organics Ltd.	47	29.50	-1.22	-27.30%	-22.27% TTM	-291.91% TTM	-55.33%

Filings & corporate actions

Recent announcements

Intimation under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 - Dispatch of Letter for Non- Email Cases4 Nov 2026 · Company Update / General
Intimation for members consent received under Regulation 30 of SEBI (LODR), 2015 for appointment of Mr. Prabhakar Zavar as an Independent Director wef. September 15 2026 for term of 5 years, ....2 Nov 2026 · Company Update / Change in Management
Disclosure of Scrutinizers Report and Voting Results purusant to Regulation 44 of SEBI (LODR), 2015 for Postal Ballot.2 Nov 2026 · AGM/EGM / Postal Ballot
Outcome of Postal Ballot pursuant to Regulation 30 of SEBI ( LODR), 2015 for appointmnt of Mr. Prabhakar Zavar as Independent Director for term of 5 years wef. September 15, 2026, who has ....2 Nov 2026 · AGM/EGM / Postal Ballot
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Financial ....29 Oct 2026 · Board Meeting / Board Meeting
Subsequent Intimation for Bank Default under Para A of Schedule III of Regulation 30 of SEBI (LODR), 2015.16 Oct 2026 · Others
Intimation of Certificate received from RTA i.e. MUFG Intime India Private Limited under Regulation 74(5) of DP, 2018 for the quarter ended September 30, 20267 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation under Regulation 30 of SEBI (LODR),2015 for Newspaper publication regarding issuance of postal ballot notice for appointment of Mr. Prabhakar Raghunath Zavar as Independent Director.3 Oct 2026 · Company Update / Newspaper Publication
Approval for the appointment of Shri Prabhakar Raghunath Zavar as an Independent Director (Non Executive Director) of the Company for term of 5 years , who has attained age of 78 years.1 Oct 2026 · AGM/EGM / Postal Ballot
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....28 Sep 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Intimation for Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading)Regulations, 2015 for the quarter ended September 30, 202625 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation pursuant to Regulation 30 of SEBI (LODR), 2015 for the term completion of M/s V.S. Somani and Co. , Chartered Accountants as Statutory Auditor in the 53rd AGM of the Company.24 Sep 2026 · Company Update / Retirement
Intimation under Regulation 30 of SEBI (LODR), 2015, post shareholders approval for appointment of M/s S. N Nanda & Co, Chartered Accountants as Statutory Auditor for 5 years from conclusion ....24 Sep 2026 · Company Update / Appointment of Statutory Auditor/s
Intimation pursuant to Regulation 30 of SEBI (LODR), 2015 for the approval of shareholders in AGM regarding appointment of Statutory and Secretarial Auditor and Retirement of term of outgoing ....24 Sep 2026 · Company Update / Change in Management
Intimation under Regulation 44 of SEBI ( LODR), 2015 regarding voting results and combined scrutinizer report for 53rd Annual General Meeting of the Company.24 Sep 2026 · AGM/EGM / AGM
Intimation for the Proceedings of the 53rd Annual General Meeting of the Company held on Wednesday, 23/09/2026 , started at 3:00 pm and concluded at 4:00 pm through video conferencing under ....23 Sep 2026 · AGM/EGM / AGM
Subsequent Disclosure under Regulation 30 Para A of Schedule III of LODR 2015 for the bank default of the Company15 Sep 2026 · Others
Disclosure under Regulation 30 of LODR, 2015 for the appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as the Additional Independent Director ( Non- Executive) for term of 5 ....15 Sep 2026 · Company Update / Change in Management
Outcome of Board Meeting pursuant to Regulation 30 of LODR for appointment of Mr. Prabhakar Raghunath Zavar as the Additional Indepedent Director ( Non- Executive) for term of 5 years wef. ....15 Sep 2026 · Board Meeting / Outcome of Board Meeting
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September, 2026 and information on E-voting.1 Sep 2026 · Company Update / Newspaper Publication
Intimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday, September 23rd, 2026 to the Shareholders of the Company.31 Aug 2026 · Others / Reg. 34 (1) Annual Report
Annual Report of the Company, Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday, September 23rd, 2026 and Intimation of Cut-off Date for ....31 Aug 2026 · AGM/EGM / AGM
Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default17 Aug 2026 · Others
Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 202613 Aug 2026 · Company Update / Newspaper Publication
Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company12 Aug 2026 · Company Update / General
Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.12 Aug 2026 · Company Update / Appointment of Statutory Auditor/s
Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 202612 Aug 2026 · Result / Financial Results
Outcome of Board meeting held on 12th August, 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June, 202612 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR), Regulations, 2015 regarding resiagntion tendered by Ragini Chokshi & Co., Secretarial Auditor of the Company ....6 Aug 2026 · Company Update / General
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Prior Intimation ....5 Aug 2026 · Board Meeting / Board Meeting
Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III16 Jul 2026 · Others
Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III15 Jul 2026 · Others
Intimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations, 201813 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of trading Window for the period ended 30th June, 202625 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....18 Jun 2026 · AGM/EGM / Postal Ballot
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director ....18 Jun 2026 · AGM/EGM / Postal Ballot
Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations, 2015 of default of Bank Loan account.17 Jun 2026 · Others
Submission of Annual Secretarial Compliance Report for the period ended 31st March, 202625 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report to be filed for the financial year ended March 31, 2026 as per Regulation 24A of SEBI LODR, 2025.25 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.19 May 2026 · Company Update / Newspaper Publication

Board meetings

5 Nov 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results